Amy C. Moore, PhD @acmoorephd.bsky.social · 03/01/2025@jfreemandaily.bsky.socialOncLive@onclive.bsky.socialTaletrectinib Approved in China for Locally Advanced/Metastatic ROS1+ #NSCLC #oncology www.onclive.com/view/taletre...onclive.comTaletrectinib Approved in China for Locally Advanced/Metastatic ROS1+ NSCLCChina's NMPA has approved taletrectinib adipate capsule for the treatment of adult patients with locally advanced or metastatic ROS1-positive NSCLC. 010
